Stockscreener 앱 받기
1.55
10.92%
-0.19
시장 영업 전:
1.72
0.17
+10.97%
전일 마감가:
$1.74
열려 있는:
$1.75
하루 거래량:
352.97K
Relative Volume:
0.26
시가총액:
$14.05M
수익:
-
순이익/손실:
$-23.36M
주가수익비율:
-2.1037
EPS:
-0.7368
순현금흐름:
-
1주 성능:
-62.20%
1개월 성능:
-82.31%
6개월 성능:
-84.83%
1년 성능:
-88.52%
1일 변동 폭
$1.54
$1.80
1주일 범위
$1.54
$4.27
52주 변동 폭
$1.54
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
명칭
Calidi Biotherapeutics Inc
전화
(858) 794-9600
주소
4475 Executive Drive, Suite 200, San Diego
CLDI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.55 | 14.05M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-22 | 개시 | H.C. Wainwright | Buy |
| 2023-10-09 | 개시 | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
Calidi prices 1.47M units at $2.00 in underwritten public offering - MSN
Calidi Biotherapeutics Prices $6 Million Public Offering to Advance Targeted Cancer Therapies - citybuzz -
Technical Bounce Expected in Calidi Biotherapeutics Inc. Next Week2025 Trading Volume Trends & Short-Term High Return Ideas - newsyoung.net
Nasdaq Down 1%; Lowe's Posts Upbeat Earnings - Benzinga
Calidi Biotherapeutics Prices $6 Million Public Offering; Shares Fall - MarketScreener
Calidi Plunges 41%: A Capital Raise Gone Wrong? - AInvest
Calidi Biotherapeutics Plunges 40% on Capital Raise - AInvest
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering - GlobeNewswire
$6M Capital Raise: Clinical-Stage Biotech Calidi Prices Offering With Strong Insider Support - Stock Titan
Why Did Calidi Biotherapeutics (CLDI) Plunge 15.33%? - AInvest
Can Calidi Biotherapeutics Inc. Escape Recent Bear ChannelJuly 2025 Drop Watch & Capital Efficient Trading Techniques - thegnnews.com
Heavy Losses Hit James Hardie, EnVVeno And Calidi Shares - Finimize
Calidi Plummets 21% on Reverse Split Jitters and Earnings Skepticism—What’s Next for the Biotech Play? - AInvest
Calidi Plummets 21% on Reverse Split Jitters and Earnings Concerns - AInvest
Has Calidi Biotherapeutics Inc. formed a bullish divergenceJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
Published on: 2025-08-16 04:46:29 - Newser
How to forecast Calidi Biotherapeutics Inc. trends using time seriesOil Prices & Technical Confirmation Trade Alerts - Newser
Is a relief rally coming for Calidi Biotherapeutics Inc. holdersTreasury Yields & Stepwise Trade Signal Guides - Newser
Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionPortfolio Profit Report & Long-Term Growth Plans - Newser
Calidi Biotherapeutics Inc. stock momentum explainedJuly 2025 Recap & Community Verified Trade Signals - Newser
How to interpret RSI for Calidi Biotherapeutics Inc. stockEarnings Recap Report & Smart Money Movement Tracker - Newser
What’s next for Calidi Biotherapeutics Inc. stock pricePrice Action & Stepwise Entry and Exit Trade Signals - Newser
Calidi Biotherapeutics Announces Executive Departure Agreement - MSN
Calidi Biotherapeutics finalizes separation agreement with Dr. Boris Minev By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics finalizes separation agreement with Dr. Boris Minev - Investing.com India
Regression analysis insights on Calidi Biotherapeutics Inc. performanceJuly 2025 Closing Moves & Smart Swing Trading Alerts - Newser
Using Bollinger Bands to evaluate Calidi Biotherapeutics Inc.Risk Management & Consistent Profit Alerts - Newser
Calidi Biotherapeutics Reports Q2 2025 Financial Results and Advances in Oncology Therapies - citybuzz -
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 - ADVFN Brasil
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pensacola News Journal
Is Calidi Biotherapeutics Inc. stock poised for growthFree Pattern Breakout Entry Stock Forecast - Newser
Calidi Biotherapeutics Q2 2025: Net Loss Narrowed to $5.7 Million, Cash Decreased to $5.3 Million. - AInvest
Calidi Biotherapeutics Secures FDA Fast Track Designation - TipRanks
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewswire
Calidi Bio Secures FDA Fast Track for Revolutionary Cancer Treatment as Q2 Shows Strong Pipeline Progress - Stock Titan
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split - TipRanks
Head to Head Comparison: Prime Medicine (NYSE:PRME) vs. Calidi Biotherapeutics (NYSE:CLDI) - Defense World
Why LyondellBasell Industries Stock Slumped Today - The Globe and Mail
How does Calidi Biotherapeutics Inc. compare to its industry peersIdentify safe investments with exceptional yields - Jammu Links News
What is Calidi Biotherapeutics Inc. company’s growth strategyAchieve breakthrough gains with smart trades - Jammu Links News
Is it the right time to buy Calidi Biotherapeutics Inc. stockExtraordinary performance - Jammu Links News
1 Green Flag for Dutch Bros Stock Right Now - The Globe and Mail
Does Calidi Biotherapeutics Inc. stock perform well during market downturnsGet timely advice on market trends - Jammu Links News
Is Calidi Biotherapeutics Inc. a growth stock or a value stockAchieve consistent profits with smart trading - Jammu Links News
What are analysts’ price targets for Calidi Biotherapeutics Inc. in the next 12 monthsBuild a winning portfolio with smart picks - Jammu Links News
What makes Calidi Biotherapeutics Inc. stock price move sharplyDiscover high-impact stocks for growth - Jammu Links News
Is Calidi Biotherapeutics Inc. stock overvalued or undervaluedExceptional trading results - Jammu Links News
What are the technical indicators suggesting about Calidi Biotherapeutics Inc.Pre Market Entry Points To Watch Now - Jammu Links News
Chart based analysis of Calidi Biotherapeutics Inc. trendsChart Driven High Reward Trading Setup Presented - metal.it
Calidi Biotherapeutics Inc (CLDI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.27%
자본화:
|
볼륨(24시간):